Forziga 10mg (dapagliflozin) film-coated tablets

Forziga is a prescription medication containing the active ingredient dapagliflozin, used primarily for the treatment of type 2 diabetes, heart failure, and chronic kidney disease. It was developed by the multinational pharmaceutical giant AstraZeneca. The specific packaging shown indicates that while the license holder for the Turkish market is AstraZeneca İlaç San. ve Tic. Ltd. Şti. based in Levent, Istanbul, the product itself is manufactured at AstraZeneca Pharmaceuticals' facility in Mt. Vernon, USA.

AstraZeneca was formed through the 1999 merger of the Swedish company Astra AB and the British company Zeneca Group PLC. Today, it stands as one of the world's largest pharmaceutical companies, headquartered in the United Kingdom. The brand Forziga (known as Farxiga in some markets) is a global product distributed through AstraZeneca's extensive international network, adhering to stringent clinical and manufacturing standards across its diverse production sites.